Exploring the Science and Practice of GLP-1 Receptor Agonists

  Рет қаралды 20,500

PeerView CME

PeerView CME

4 жыл бұрын

Chair, John B. Buse, MD, PhD, discusses type 2 diabetes in this CME activity titled "Exploring the Science and Practice of GLP-1 Receptor Agonists: An Update on Current and Emerging Evidence.” For the full presentation, downloadable infographics, complete CME information, and to apply for credit, please visit us at PeerView.com/YYH865. CME credit will be available until October 21, 2020.

Пікірлер
What is GLP-1, What Does It Do, and Where Does It Come From? with Dr. Ben Bikman
47:52
What is GLP-1, What Does It Do, and Where Does It Come From? with Dr. Ben Bikman
Insulin IQ
Рет қаралды 48 М.
How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments
1:02:08
How GLP-1 Receptor Agonists Evolved from Diabetes to Weight Loss Treatments
Drug Hunter
Рет қаралды 3,1 М.
THEY made a RAINBOW M&M 🤩😳 LeoNata family #shorts
00:49
THEY made a RAINBOW M&M 🤩😳 LeoNata family #shorts
LeoNata Family
Рет қаралды 42 МЛН
New model rc bird unboxing and testing
00:10
New model rc bird unboxing and testing
Ruhul Shorts
Рет қаралды 23 МЛН
Slow motion boy #shorts by Tsuriki Show
00:14
Slow motion boy #shorts by Tsuriki Show
Tsuriki Show
Рет қаралды 7 МЛН
ПРЕВРАТИЛИ ВСЁ В ТОРТ! *ТОРТ ИЛИ ФЕЙК ЧЕЛЛЕНДЖ* #Shorts #Глент
00:22
ПРЕВРАТИЛИ ВСЁ В ТОРТ! *ТОРТ ИЛИ ФЕЙК ЧЕЛЛЕНДЖ* #Shorts #Глент
ГЛЕНТ
Рет қаралды 7 МЛН
The Increasing Importance of GLP-1-Based Therapies for Personalized Obesity Management
58:16
The Increasing Importance of GLP-1-Based Therapies for Personalized Obesity Management
PeerView CME
Рет қаралды 14 М.
How to Avoid Insulin Resistance and Why it's Important | Dr. Robert Lustig & Dr. Dom D'Agostino
1:17:18
How to Avoid Insulin Resistance and Why it's Important | Dr. Robert Lustig & Dr. Dom D'Agostino
Levels
Рет қаралды 484 М.
Practical Use of Oral Antidiabetic Agents
52:01
Practical Use of Oral Antidiabetic Agents
Emory Department of Medicine
Рет қаралды 72 М.
Using SGLT2-inhibitors to treat cardiac patients with diabetes
13:49
Using SGLT2-inhibitors to treat cardiac patients with diabetes
Ted Rogers Centre for Heart Research
Рет қаралды 33 М.
Navigating GLP-1 agonists | DoM Grand Rounds | 17 January 2024
1:07:25
Navigating GLP-1 agonists | DoM Grand Rounds | 17 January 2024
Stanford Department of Medicine
Рет қаралды 3,8 М.
Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists
7:43
Choosing SGLT2 Inhibitors vs GLP-1 Receptor Agonists
Harvard Medical School Continuing Education
Рет қаралды 15 М.
Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity
1:05:21
Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity
PeerView CME
Рет қаралды 17 М.
The GLP-1 Story... (a GoggleDocs Podcast)
58:36
The GLP-1 Story... (a GoggleDocs Podcast)
GoggleDocs
Рет қаралды 196
How GLP-1 Agonists Are Changing Obesity Care with Dr. Spencer Nadolsky
1:15:28
How GLP-1 Agonists Are Changing Obesity Care with Dr. Spencer Nadolsky
InsideTracker
Рет қаралды 8 М.
Are There Natural GLP-1 Agonists?
13:15
Are There Natural GLP-1 Agonists?
Dr. Kate Lyzenga-Dean
Рет қаралды 50 М.
THEY made a RAINBOW M&M 🤩😳 LeoNata family #shorts
00:49
THEY made a RAINBOW M&M 🤩😳 LeoNata family #shorts
LeoNata Family
Рет қаралды 42 МЛН